Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Vendor Ranking Analysis
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. Increasing demand for specialty drugs to treat complex or serious chronic conditions
4.4.1.2. Increased reimbursement through the medical benefit, and pharmacy benefit
4.4.1.3. Specialty pharmacy providers collaborating with pharma/biotech manufacturers, payers, MCOs and patients
4.4.1.4. Attractive prospects for biopharmaceutical companies from both business and medical innovation perspective
4.4.2. Restraints
4.4.2.1. Cost sharing discourages the use leading to adverse health outcomes
4.4.2.2. Growth in premium costs
4.4.3. Opportunities
4.4.3.1. Retailers involvements in specialty market and several chains operate their own specialty pharmacy divisions
4.4.3.2. Stimulated diagnostic research
4.4.3.3. Vendors offering compliance programs, reimbursement assistance programs and distribution channels
4.4.3.4. Growth of enhanced information technologies in the specialty sector
4.4.3.5. Value-added programs targeting physicians, nurses, patients and caregivers
4.4.4. Challenges
4.4.4.1. Less focus on development of low-cost generic equivalents of specialty drugs
4.5. Porter's Five Forces Analysis
4.5.1. Threat of New Entrants
4.5.2. Threat of Substitutes
4.5.3. Bargaining Power of Customers
4.5.4. Bargaining Power of Suppliers
4.5.5. Industry Rivalry
4.6. Regulatory Framework
4.7. Value Chain Analysis
5. Global Specialty Pharmaceuticals Market, by Type
5.1. Introduction
5.2. CNS
5.3. Infectious diseases
5.4. Momen's health
5.5. Oncology
5.6. Respiratory
6. Global Specialty Pharmaceuticals Market, by Distribution Channel
6.1. Introduction
6.2. Infectious Diseases
6.3. Physician Clinics
6.4. Retail and specialty pharmacies
7. Global Specialty Pharmaceuticals Market, by Geography
7.1. Introduction
7.2. Americas Specialty Pharmaceuticals Market
7.2.1. Americas Specialty Pharmaceuticals Market, by Country
7.2.1.1. United States
7.2.1.2. Brazil
7.2.1.3. Canada
7.2.1.4. Mexico
7.2.1.5. Argentina
7.2.2. Americas Specialty Pharmaceuticals Market, by Type
7.2.3. Americas Specialty Pharmaceuticals Market, by Distribution Channel
7.3. Europe, Middle East & Africa Specialty Pharmaceuticals Market
7.3.1. Europe, Middle East & Africa Specialty Pharmaceuticals Market, by Country
7.3.1.1. United Kingdom
7.3.1.2. Germany
7.3.1.3. France
7.3.1.4. Saudi Arabia
7.3.1.5. United Arab Emirates
7.3.1.6. Italy
7.3.1.7. Russia
7.3.2. Europe, Middle East & Africa Specialty Pharmaceuticals Market, by Type
7.3.3. Europe, Middle East & Africa Specialty Pharmaceuticals Market, by Distribution Channel
7.4. Asia-Pacific Specialty Pharmaceuticals Market
7.4.1. Asia-Pacific Specialty Pharmaceuticals Market, by Country
7.4.1.1. China
7.4.1.2. Japan
7.4.1.3. India
7.4.1.4. Australia
7.4.2. Asia-Pacific Specialty Pharmaceuticals Market, by Type
7.4.3. Asia-Pacific Specialty Pharmaceuticals Market, by Distribution Channel
8. 360iResearch Competitive Strategic Window
8.1. Introduction
8.1.1. Leverage Zone
8.1.2. Vantage Zone
8.1.3. Speculative Zone
8.1.4. Bottleneck Zone
9. 360iResearch FPNV Positioning Matrix
9.1. Introduction
9.2. 360iResearch Scores
9.2.1. Forefront
9.2.2. Pathfinders
9.2.3. Niche
9.2.4. Vital
9.3. Business Strategy
9.4. Product Satisfaction
10. Competitive News Feed Analysis
11. Company Usability Profiles
11.1. Accredo Health Group, Inc.
11.2. Avella Specialty Pharmacy, Inc.
11.3. CIGNA Pharmacy Management
11.4. CVS Health Corporation
11.5. Diplomat Pharmacy, Inc.
11.6. ENESI
11.7. Endo Pharmaceuticals Inc.
11.8. Humana Pharmacy, Inc.
11.9. Hyphens Pharma Pte Ltd.
11.10. Kroger Specialty Pharmacy, Inc.
11.11. McKesson Corporation
11.12. Midatech Pharma PLC
11.13. US WorldMeds, LLC
11.14. UnitedHealth Group Incorporated
11.15. Walgreens Boots Alliance, Inc.
12. Appendix
12.1. Top Reports
12.2. Author Details

LIST OF TABLES (28 TABLES)

TABLE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN'S HEALTH, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)
TABLE 10. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 11. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PHYSICIAN CLINICS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 14. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 15. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 16. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)
TABLE 17. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)
TABLE 20. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 21. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 22. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)
TABLE 23. 360IRESEARCH SCORES FOR FOREFRONT IN SPECIALTY PHARMACEUTICALS MARKET
TABLE 24. 360IRESEARCH SCORES FOR PATHFINDERS IN SPECIALTY PHARMACEUTICALS MARKET
TABLE 25. 360IRESEARCH SCORES FOR NICHE IN SPECIALTY PHARMACEUTICALS MARKET
TABLE 26. 360IRESEARCH SCORES FOR VITAL IN SPECIALTY PHARMACEUTICALS MARKET
TABLE 27. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR SPECIALTY PHARMACEUTICALS MARKET
TABLE 28. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR SPECIALTY PHARMACEUTICALS MARKET

LIST OF FIGURES (26 TABLES)

FIGURE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. SPECIALTY PHARMACEUTICALS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)
FIGURE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD BILLION)
FIGURE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 14. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 15. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN'S HEALTH, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 16. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 17. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 18. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017 VS 2024 (USD BILLION)
FIGURE 19. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 20. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PHYSICIAN CLINICS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 21. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 22. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY TYPE, 2024
FIGURE 24. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 25. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY GEOGRAPHY, 2024
FIGURE 26. 360IRESEARCH FPNV POSITIONING MATRIX FOR SPECIALTY PHARMACEUTICALS MARKET